SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-080624
Filing Date
2024-03-28
Accepted
2024-03-28 16:12:56
Documents
6
Effectiveness Date
2024-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 POS d793712ds8pos.htm S-8 POS 67185
2 EX-4.5 d793712dex45.htm EX-4.5 140600
3 EX-5.5 d793712dex55.htm EX-5.5 6144
4 EX-23.6 d793712dex236.htm EX-23.6 2206
5 GRAPHIC g793712g0328161238734.jpg GRAPHIC 2219
6 GRAPHIC g793712page26.jpg GRAPHIC 3032
  Complete submission text file 0001193125-24-080624.txt   225031
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-240996 | Film No.: 24799051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)